Who We Are

Jennifer R. Stickel, PhD serves on the IAC Nuclear/PET Board of Directors as a representative of the American Association of Physicists in Medicine (AAPM). Ms. Stickel is currently VP - Diagnostic and Nuclear Medicine Physics for the Colorado Associates in Medical Physics in Colorado Springs, Colo, and is also the nuclear medicine trustee for the ABR. She earned her BS in Biomedical Engineering from Boston University in 2001, prior to obtaining her PhD in the field from the University of California in 2006. In addition to AAPM, she is also a member of the Society of Nuclear Medicine (SNM) and the American College of Radiology (ACR). She lives with her husband and two kids in the foothills of the Rocky Mountains.

Phillip Kuo, MD, PhD, FACR serves on the IAC Nuclear/PET Board of Directors as the representative of the American College of Nuclear Medicine (ACNM). Dr. Kuo graduated in chemistry from Harvard University and then earned an MD/PhD from University of Virginia. Post-graduate training included residencies in internal medicine at University of California Los Angeles and Nuclear Medicine and Radiology at Yale. He is Professor of Radiology, Section Chief of Nuclear Medicine, and Director of Theranostics for the Department of Radiology at City of Hope National Medical Center. He provides expertise in the design, conduct, analysis, and reporting of phase 1-3 clinical trials covering a wide range of diseases. He has more than 140 peer-reviewed publications and has served as PI or co-PI on numerous NIH grants and industry-sponsored clinical trials.

Katherine Zukotynski, MD, PhD serves on the IAC Nuclear/PET Board of Directors as the representative of the American College of Nuclear Medicine (ACNM). A Professor in the Department of Medical Imaging at McMaster University, she is certified in radiology, nuclear medicine and nuclear cardiology in the United States. Dr. Zukotynski is also a Fellow of the Royal College of Physicians and Surgeons of Canada with sub-speciality training in radiology and nuclear medicine as well as a licensed Professional Engineer in Ontario. Her research is in dementia imaging, prostate cancer imaging/ therapy and artificial intelligence. She is Associate Co-Chair of Research in her academic Department, Vice Chair of Finance for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and past President of the American College of Nuclear Medicine (ACNM). She has been named a Fellow of the ACNM and a Fellow of the SNMMI for her contributions to the field and our community.

Mylan Cohen, MD, MPH, FACC, MASNC serves on the IAC Nuclear/PET Board of Directors as a representative of the American Society of Nuclear Cardiology (ASNC). Dr. Cohen received his MD degree from the University of Vermont College of Medicine and his MPH degree from the Harvard School of Public Health. He completed his internship and residency in internal medicine and his clinical and research cardiology fellowships at Beth Israel Deaconess Medical Center in Boston. Dr. Cohen practices clinical cardiology with MaineHealth Cardiology. He is the Medical Director of the Cardiac Imaging and Diagnostics Section of the Cardiology Division at Maine Medical Center and for MaineHealth Cardiovascular Service Line. He is a Professor of Medicine at Tufts University School of Medicine. Dr. Cohen served on the Board of Directors and Executive Council for ASNC for a total of 13 years and in 2010 was privileged to serve as the President of ASNC. His activities include clinical care of patients, administration, research and teaching.

Scott D. Jerome, DO, FACC, FASNC, FSCCT serves on the IAC Nuclear/PET Board of Directors as a representative of the American Society of Nuclear Cardiology (ASNC). Upon receiving his medical degree with honors from the West Virginia School of Osteopathic Medicine, Dr. Jerome completed his medicine residency at Sinai Hospital in Baltimore and his cardiology fellowship at Wayne State University in Detroit. Dr. Jerome is the Director of Ambulatory Services and Outreach of the Division of Cardiovascular Medicine and the Director of Sports Cardiology at the University of Maryland School of Medicine. He is also a full-time faculty member at the University of Maryland School of Medicine. Dr. Jerome is a fellow of ASNC, the American College of Cardiology (ACC), and the Society of Cardiovascular Computed Tomography (SCCT). He has authored and co-authored numerous publications and is actively involved in all aspects of cardiac imaging. He is also engaged in informatics integration.

Jimel Carpenter, MS, RT(N), CNMT, NCT, RDMS serves on the IAC Nuclear/PET Board of Directors as a representative of the American Society of Radiologic Technologists (ASRT). A Georgia native, Mr. Carpenter completed both his Nuclear Medicine Technology training and Bachelor’s degree in Radiologic Science at Augusta University, formally The Medical College of Georgia. He later received his MS degree in Healthcare Management from Troy University. With more than 28 years of experience in Nuclear Medicine Technology, Sonography and Administration. Mr. Carpenter has worked as a Nuclear Medicine Technologist and leader at the Charlie Norwood Augusta VA Medical Center, University Hospital, and the Augusta University Medical Center. He currently serves as the Director for Cardiovascular Non-Invasive Services at Piedmont Health Care System in Augusta, GA. Throughout his career, Mr. Carpenter has presented and led Nuclear Medicine Technology workshops at local, state and chapter level Nuclear Medicine Technology meetings. Jimel has also been credited as a technical contributor in a number of scientific publications. In addition to his IAC involvement, Mr. Carpenter has served two terms as a member of the Nuclear Medicine Technology Certification Board’s (NMTCB) Board of Directors, including being elected Board chair in 2013. Jimel currently holds the office of President-Elect for the IAC Nuclear/PET Board and will begin his term as President in 2025.

Erin Grady, MD, CCD, FACNM is the Associate Chair of Education and Diversity, Equity and Inclusion, program director for the nuclear radiology fellowship, and a nuclear medicine physician at Stanford Hospital and Clinics in Stanford, California. She is actively involved nationally in the SNMMI in multiple capacities including as a Director-at-Large on the SNMMI Board of Directors, chair of the Nuclear Medicine Program Directors, a member of the General Nuclear Medicine Council board, co-chair of the Government Relations Committee and a longstanding member of the Coding and Reimbursement Committee. In addition, she is a past chair of the American Board of Nuclear Medicine and has served on the board of appeals panel, review committee and milestone development committee for Nuclear Medicine and milestone revision committee for Nuclear Radiology at the ACGME. Her areas of research interest include quality, education, radiopharmaceutical therapy and finding answers to clinical questions that arise during the course of practice. She is passionate about education in nuclear medicine, nuclear medicine’s future and is a staunch advocate for patients.

Daniel J. Lee, MD serves on the IAC Nuclear/PET Board of Directors as a representative of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Lee is Associate Professor of Radiology and Director of Nuclear Medicine Quality and Safety at University of Texas Southwestern Medical Center in Dallas, TX. He is also Medical Director for Nuclear Medicine at Parkland Memorial Hospital, also in Dallas, TX. After completing his residency at Memorial Sloan Kettering Cancer Center in New York, he practiced at University of Rochester, Emory University, Ochsner Medical Center before joining UT Southwestern Medical Center in 2023. He is co-chair of the Therapy Strategic Planning Task Force for SNMMI, immediate past president of the Therapy Center of Excellence, and a past chair of the Nuclear Medicine Program Director's Association. His interests include oncologic imaging and radiopharmaceutical therapy.

Heather Jacene, MD serves on the IAC Nuclear/PET Board of Directors as a representative of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Jacene is Assistant Chief of Nuclear Medicine at Brigham and Women’s Hospital, Clinical Director of Nuclear Medicine at Dana-Farber Cancer Institute and an Associate Professor of Radiology at Harvard Medical School. She completed her residency and fellowship in Nuclear Medicine and PET/CT at Johns Hopkins University. Dr. Jacene has served as a Director on the American Board of Nuclear Medicine (ACNM) as well as on numerous committees within the SNMMI. Her current positions include Chair of the Scientific Program Committee and Chair of the Quality of Practice Domain for SNMMI. Dr. Jacene has vast expertise in the interpretation of oncology PET/CT scans and in treating various tumor types with radiopharmaceutical therapy. She extends this expertise to her research which focuses on the use of FDG-PET/CT and other novel tracers for characterizing and monitoring response of cancer to therapy, as well as the use of radiopharmaceutical therapy. She has over 85 peer-reviewed publications as well as many reviews and book chapters on these and other nuclear medicine related topics.

Thomas H. Schindler, MD, PhD serves on the IAC Nuclear/PET Board of Directors as a representative of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Schindler is currently an associate professor of radiology and medicine as well at the head of cardiovascular PET/CT at the Washington University in St. Louis, MO. He also serves as an adjunct associate professor of medicine at Johns Hopkins University in Baltimore, MD. Additionally from February 2013- December 2017, Dr. Schindler was Johns Hopkins University’s director of nuclear cardiovascular medicine. Dr. Schindler has an international reputation in the field of cardiovascular imaging with a focus on cardiovascular PET/CT. He received both his medical degree in 1995 and doctorate of medicine in 1996 from the University of Leipzig in Germany where he graduated magna cum laude. He is board certified in internal medicine, cardiology and nuclear cardiology. From 2002 to 2006, Dr. Schindler completed a National Institutes of Health (NIH) sponsored postdoctoral fellowship in cardiac PET imaging at the David Geffen School of Medicine at UCLA, where he was mentored by Dr. Heinrich R. Schelbert, MD, PhD. Subsequently, from 2006-2013, Dr. Schindler joined the faculty of the University of Geneva in Switzerland as an assistant professor and clinical attending physician in cardiovascular imaging and general clinical cardiology. He was then promoted to privat-docent in 2009 and deputy head physician in cardiology in 2010. Dr. Schindler has authored more than 154 peer review publications with an impact factor exceeding 800 along with numerous book chapters. He has been a member of the Board of Directors for SNMMI, European Association of Nuclear Medicine (EANM), European Society of Cardiology (ESC) and is involved in numerous conferences as an organizer and invited speaker. Dr. Schindler’s research has made major contributions in the identification and characterization of coronary circulatory dysfunction, cardiac sarcoidosis and myocardial receptor imaging by means of PET. He received the 2020 Presidential Distinguished Educator Award and the 2018 Cardiovascular Council Hermann Blumgart Award from SNMMI.

Richard L. Wahl, MD Richard L. Wahl, MD serves on the IAC Nuclear/PET Board of Directors as a representative of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Wahl recently completed his term as the Elizabeth E. Mallinckrodt Professor and head of radiology at the Washington University School of Medicine in St. Louis, the director of the university’s Mallinckrodt Institute of Radiology. He is currently a professor of radiology and radiation oncology. Dr. Wahl graduated from the Wartburg College in Waverly, IA with a major in Chemistry. He went on to also graduate from the Washington University School of Medicine and then intern in internal medicine at the University of California San Diego School of Medicine. He returned to Washington University in 1979 for training in diagnostic radiology, nuclear medicine and immunology research. Dr. Wahl then joined the faculty at the University of Michigan in 1983 where he advanced to professor. He moved to Johns Hopkins University in 2000 where he served as the first Henry N. Wagner Jr. Professor of nuclear medicine, chief of nuclear medicine and as a vice chair of radiology. He joined the faculty of Washington University in 2014. Dr. Wahl’s research played an important role in the development of two FDA approved radio immunotherapies for non-Hodgkin's lymphoma. He has been a pioneer in the use of PET scans to diagnose and assess treatment of a broad array of human cancers and other diseases, and led efforts to combine quantitative data from PET scans with computerized tomography (CT) to form “fusion” images that now routinely help physicians more precisely diagnose and characterize cancers. Dr. Wahl and colleagues developed the PERCIST 1.0 criteria for assessing treatment response in cancer. Dr. Wahl is a world-renowned leader in molecular imaging and radiopharmaceutical therapy. Over the past 40 years, his contributions have touched nearly every aspect of the field and spans from the bench to the bedside. He has been involved in the training of many leaders in nuclear medicine and radiology. Dr. Wahl is an elected member of the National Academy of Medicine (NAM) and has received honors from multiple organizations. He holds 18 patents and has published more than 500 peer-reviewed scientific manuscripts. He is the primary author of several textbooks, including Principles and Practice of PET and PET/CT. He has a strong interest in quantitative imaging, has been on the coordinating committee of the Quantitative Imaging Biomarkers Alliance (QIBA) efforts of the Radiological Society of North America (RSNA) and has been a lead investigator for the National Institutes of Health’s (NIH) Quantitative Imaging Network (QIN). He continues to practice nuclear medicine and is active in research and education.

Jaime Warren, Ed.D, MBA, BHS, CNMT, NCT, FACC Dr. Jaime Warren holds a Doctor of Education in Leadership and Learning with a specialization in Health Care Administration and Leadership, a Master of Business of Administration, and a Bachelor of Health Science in Nuclear Medicine Technology. Dr. Warren possesses over 25 years of clinical and operational experience, serves as Vice-President of consulting at MedAxiom (An ACC company), and specializes in operational leadership. She serves on the IAC Nuclear/PET Board of Directors as the representative of the Society of Nuclear Medicine and Molecular Imaging - Technologist Section (SNMMI-TS).

Mark C. Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC serves on the IAC Nuclear/PET Board of Directors as the representative of the Society of Nuclear Medicine and Molecular Imaging – Technologist Section (SNMMI-TS). Mr. Hyun is currently a nuclear medicine/nuclear cardiology research imaging specialist and cardiac CT technologist at Cedars-Sinai Medical Center in Los Angeles, CA. Prior to returning to Cedars, he was a chief nuclear medicine technologist at an outpatient imaging center for nearly 10 years. He formerly served as a technical manager of the nuclear medicine department at Cedars for more than 15 years. Mr. Hyun received his education and clinical training from LAC-USC School of Radiologic and Nuclear Medicine Technology, where he received the Outstanding Student awards during his programs. Recently, he served as a committee member and program track chair for the American Society of Nuclear Medicine (ASNC) Annual Meeting and is now serving as a chair of the technologist advisory panel. He holds numerous certifications in nuclear medicine and radiologic and computed tomography technology from California and the American Registry of Radiologic Technologists (ARRT). He is also board certified by the Nuclear Medicine Technology Certification Board (NMTCB), including in the specialties of Nuclear Cardiology Technologist (NCT) and Radiation Safety (RS). In addition to SNMMI and ASNC he is a member of professional organizations, including the American Society of Radiologic Technologists (ASRT) and the Los Angeles Radiologic Society (LARS). Mr. Hyun has authored and co-authored many articles in the Journal of Nuclear Cardiology and the Journal of Nuclear Medicine. Most of which coincide with his special interests in nuclear cardiology research and technology. In addition, he has been an abstracts and manuscripts reviewer for the Journal of Nuclear Medicine Technology and the Journal of Nuclear Cardiology. Over the years, he has given numerous presentations and lectures at SNMMI, ASNC, ASRT, LARS, and American College of Cardiology (ACC) conferences. He also serves as a technical consultant and application specialist for many major nuclear imaging and pharmaceutical vendors.

Esma A. Akin, MD, FACR serves on the IAC Nuclear/PET Board of Directors as a representative of the World Molecular Imaging Society (WMIS).

Michael Morris, MD, MS serves on the IAC Nuclear/PET Board of Directors as a representative of the World Molecular Imaging Society (WMIS). Dr. Morris founded Advanced Molecular Imaging and Therapy (AMIT) with a mission dedicated toward the use and study of theranostics agents to image and treat oncologic disease. Dr. Morris’ is board certified in diagnostic radiology and nuclear medicine. His academic and professional career is dedicated to nuclear medicine and oncoradiology with the goal to help his patients manage their disease and to better understand and treat cancer through novel molecular targeted radiopharmaceutical therapeutic and quantitative imaging approaches. Currently, AMIT is focusing on areas related to neuroendocrine malignancy, pheochromocytoma, renal cancer, prostate cancer, breast cancer, merkel cell cancer, dosimetry, innovative alpha therapies, receptor PET quantification, Zr-PET, and Immuno-PET. Dr. Morris also has developed his professional practice as a clinical informatics physician. This role has allowed Dr. Morris to collaborate on multiple cross-institutional informatics efforts at academic institutions, private medical systems, within the healthcare industry, and also to support charitable health outreach and education efforts domestically and abroad. His clinical informatics work has focused largely on quantitative imaging, imaging informatics, health cybersecurity, and real-time big data analytics to improve healthcare decision-making and allow more personalized medical care for patients. Currently, these efforts are dedicated to improving clinical dosimetry in the evaluation and treatment of patients with nuclear medicine procedures where he serves as a primary investigator or sub-investigator on multiple clinical trials and investigatory research involving tissue level dosimetry, pre-treatment planning dosimetry, and post-treatment dosimetry. Dr. Morris is involved in the precision radiopharmaceutical treatment planning and dosimetry group at the NIH Clinical Center Radiology and Imaging Sciences (RADIS) division. He is an adjunct faculty in the computer science and electrical engineering department at the University of Maryland, and serves as an affiliate member of the University of Miami Institute for Data Science (IDSC) where he is also an adjunct faculty at the University of Miami Miller School of Medicine in the Department of Diagnostic Radiology and Nuclear Medicine.

Jamieson Bourque, MD, MHS serves as Officer-at-Large on the IAC Board of Directors and on the IAC Nuclear/PET Board of Directors as a Cardiology Member-At-Large. Dr. Bourque is the Medical Director of Nuclear Cardiology at the University of Virginia, where he is a Professor of Medicine and Radiology. He also serves as Medical Director of Cardiology at the Novant-UVA Culpeper Health System. He received his BA from the University of Virginia and his medical degree and masters in health sciences in clinical research at Duke University, where he also completed his internal medicine residency. He accomplished a fellowship in cardiovascular disease and advanced fellowship in cardiovascular imaging at the University of Virginia before joining the faculty, where he is now an associate professor of medicine and radiology. He serves on the editorial board of the Journal of Nuclear Cardiology, as an editorial consultant to JACC: Cardiovascular Imaging, and sits on the cardiology steering board for Epic.

Howard Lewin, MD, FACC, FASNC serves on the IAC Nuclear/PET Board of Directors as a Member-at-Large. Dr. Lewin is presently the Director of Cardiac Imaging Associates in Los Angeles. After receiving his medical degree from Albert Einstein College of Medicine, he completed his residency training in Internal Medicine at The New York Hospital/Cornell University Medical Center in New York. Dr. Lewin then completed a fellowship in cardiology at Cedars-Sinai Medical Center in Los Angeles with advanced training in both Nuclear Cardiology and Echocardiography as well as a fellowship in Nuclear Medicine at Cedars-Sinai Medical Center. He is currently a Diplomate of the American Board of Internal Medicine in Cardiovascular Diseases and the American Board of Nuclear Medicine and is on the ASNC Health Policy Committee and the ACC Imaging Council. He serves on the Board of Directors for the Certification Council of Cardiovascular Imaging and the SNMMI Cardiovascular Council and has previously served on the Board of Directors for the American Society of Nuclear Cardiology (ASNC), Certification Board of Nuclear Cardiology and the American College of Cardiology CardioSurve research panel. In addition, Dr. Lewin has served as the chair of the CBNC Exam Committee and on the ASNC PET Taskforce as well as on the board of directors as Secretary and Treasurer of the Certification Board of Nuclear Cardiology. He is also a founding Board Member (Treasurer) of the Council for Certification of Cardiovascular Imaging and has been awarded fellow status by the American College of Cardiology (ACC) and American Society of Nuclear Cardiology (ASNC) for his contributions to the field. While Dr. Lewin’s research interests are vast, he has most recently focused his attention on clinical cardiac PET.

Irene Cruite, MD serves on the IAC Nuclear/PET Board of Directors as a Member-at-Large. Dr. Cruite is a partner radiologist with Inland Imaging in Spokane, WA. She is dual Board Certified by the American Board of Radiology and the American Board of Nuclear Medicine. She is sub-specialized in body imaging, oncology imaging and nuclear medicine/PET imaging. After graduating with Bachelor of Medicine, Bachelor of Surgery degree from the College of Health Sciences, University of Nairobi, Kenya, Dr. Cruite completed her radiology residency at the Royal College of Surgeons in Ireland. She then did a postgraduate fellowship in liver imaging with the Liver Imaging Group at the University of California, San Diego, followed by body imaging fellowship, oncology imaging fellowship and nuclear medicine residency at the University of Washington in Seattle. Dr. Cruite is an active member of several professional societies including the American College of Radiology (ACR), the Radiological Society of North America (RSNA), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Society of Abdominal Radiology (SAR), the International Society for Magnetic Resonance in Medicine (ISMRM), and the American Roentgen Ray Society (ARRS). She also serves on committees in the ACR and SAR. Dr. Cruite has published manuscripts and book chapters and presented abstracts in local and international conferences. She lives in Spokane with her husband and son. In her free time she enjoys spending time with her family and traveling.

Mary Lally, MS, CAE is the Chief Executive Officer at the Intersocietal Accreditation Commission (IAC). Ms. Lally began her tenure with the IAC in 2007, serving as Director of Accreditation. In this role she has been instrumental in the development and oversight of the IAC’s MRI and CT diagnostic divisions as well as the Carotid Stenting, Cardiac Electrophysiology and Cardiovascular Catheterization therapeutic divisions. Ms. Lally has a unique combined background of clinical expertise and association management experience, possessing both a Master’s degree in Radiation Health Physics as well as the Certified Association Executive (CAE) credential. Before joining the IAC, Ms. Lally gained more than 20 years of clinical, operational and leadership experience, serving as the founding MRI program director at the Johns Hopkins Hospital. In addition, she developed and implemented radiology quality assurance programs with emphasis in the vascular surgery, interventional and cardiology departments at the University of Maryland Hospital. An ARRT-certified MRI Technologist, Ms. Lally is a passionate advocate for quality and safety in imaging.

Maria Costello, MBA, CAE, CNMT, NCT is the IAC Chief Operations Officer (COO) and Director of Accreditation for Nuclear/PET at the Intersocietal Accreditation Commission. Joining the IAC in 2006, she served as an application reviewer before being named Director of Accreditation in 2014 and was appointed to COO in 2024. Ms. Costello has clinical experience as a nuclear medicine technologist and has held various leadership positions throughout her career. . She earned her bachelor’s degree in biology from Wilkes University in Wilkes Barre, Pa., her MBA from Southern New Hampshire University in Manchester, NH.